Abstract |
The objective of this study was to clarify the role of a novel agonist with high selectivity and affinity for Y4 receptors in the regulation of food intake. The Y4 receptor agonist BVD-74D was administered to C57BL/6J mice that were fed with a normal or high-fat diet, and to fatty liver Shionogi (FLS)-ob/ob mice; the food intake, water intake, and body weight gain were measured in these mice. In the mice fed with a normal diet, the cumulative food intake significantly decreased at 20 min and 1 h after the administration of 1 mg/kg of BVD-74D and at 1, 2, 4, 8, and 24 h after the administration of 10 mg/kg of BVD-74D. Moreover, the cumulative water intake and body weight gain significantly decreased in these mice. Among the mice that were fed with a high-fat diet, the cumulative food intake and water intake significantly decreased 1, 2, and 4 h after BVD-74D (10 mg/kg) administration. Furthermore, the cumulative food intake significantly decreased 2 and 4 h after BVD-74D (10 mg/kg) administration in the FLS-ob/ob mice. Thus, we propose that the novel Y4 receptor agonist BVD-74D has suppressive effects on food intake, water intake, and weight gain in normal mice fed with normal diets and on food intake in normal mice fed with high-fat diets and in FLS-ob/ob mice. These findings indicate that the Y4 receptor and its agonist would be promising targets for obesity.
|
Authors | Jiang-Bo Li, Akihiro Asakawa, Mutsumi Terashi, KaiChun Cheng, Huhe Chaolu, Takahiro Zoshiki, Miharu Ushikai, Sulaiman Sheriff, Ambikaipakan Balasubramaniam, Akio Inui |
Journal | Peptides
(Peptides)
Vol. 31
Issue 9
Pg. 1706-10
(Sep 2010)
ISSN: 1873-5169 [Electronic] United States |
PMID | 20600429
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | Copyright 2010 Elsevier Inc. All rights reserved. |
Chemical References |
- Anti-Obesity Agents
- Appetite Depressants
- BVD-74D peptide
- Dietary Fats
- Peptides
- Receptors, Neuropeptide Y
- neuropeptide Y4 receptor
|
Topics |
- Animals
- Anti-Obesity Agents
(adverse effects, therapeutic use)
- Anxiety
(chemically induced)
- Appetite Depressants
(adverse effects, therapeutic use)
- Appetite Regulation
(drug effects)
- Behavior, Animal
(drug effects)
- Dietary Fats
(administration & dosage)
- Dose-Response Relationship, Drug
- Drinking
(drug effects)
- Fatty Liver
(drug therapy)
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Obese
- Obesity
(drug therapy)
- Peptides
(adverse effects, therapeutic use)
- Receptors, Neuropeptide Y
(agonists)
- Time Factors
- Weight Gain
(drug effects)
|